Oragenics, Inc., a world leader in oral health probiotics for humans and companion pets, announced that it has entered into a new three year contract with Central Business USA. Under the terms of the agreement, Central Business USA will be the exclusive distributor of Oragenics' Oral Care Probiotics for Adults, Kids and Pets in Brazil, Argentina, Paraguay and Uruguay. All products will contain ProBiora3; the Company's patented proprietary blend of three probiotics specifically designed for oral health.
Central Business USA is a U.S.-based pharmaceutical wholesaler located in Orlando, Fla., that provides prescription medication, medical products, vitamins and supplements to the U.S. and South American market. They specialize in "new medications" that are not yet available to hospitals, clinics and doctors.
"This latest agreement reinforces Oragenics' strategy to continue to expand the oral probiotic product line in the international market. We are confident that in concert with Central Business USA, we can develop a substantial market in these four countries. This partnership positions the Company for further success," stated John N. Bonfiglio PhD, president and CEO of Oragenics.